The Impact of Chronic Kidney Disease on Mid-Term Outcomes after Revascularisation of Peripheral Arterial Occlusive Disease: Results from a Prospective Cohort Study.
Artur KotovDeven A BlascheFrederik PetersPhilip Thomas PospiechUlrich RotherKonstantinos StavroulakisJürgen RemigChristian Schmidt-LauberThomas ZellerHartmut GörtzJörg TeßarekChristian-Alexander BehrendtPublished in: Journal of clinical medicine (2022)
In the current study on mid-term outcomes after invasive revascularisation for symptomatic PAOD, one out of five patients suffered from any CKD while those few with ESKD had twice the odds of death, of amputation or death, and of major adverse cardiovascular events after twelve months. These results emphasise that concomitant CKD and its impact on outcomes should be considered by severity while mild and moderate grades should not lead to ineffectual treatment strategies.
Keyphrases
- chronic kidney disease
- end stage renal disease
- cardiovascular events
- peritoneal dialysis
- ejection fraction
- cardiovascular disease
- prognostic factors
- emergency department
- type diabetes
- metabolic syndrome
- high intensity
- skeletal muscle
- adipose tissue
- lower limb
- patient reported outcomes
- glycemic control
- electronic health record
- drug induced